AAAAAA

   
Results: 1-9 |
Results: 9
NOVEL NONPROSTANOID PROSTACYCLIN (PGI(2)) MIMETICS WITH HETEROCYCLIC MOIETY
Authors: NAGAO Y TAKAHASHI K TORISU K KONDO K HAMANAKA N
Citation: Y. Nagao et al., NOVEL NONPROSTANOID PROSTACYCLIN (PGI(2)) MIMETICS WITH HETEROCYCLIC MOIETY, Heterocycles, 42(2), 1996, pp. 517-523
MRI OF ANTERIOR CRUCIATE LIGAMENT HEALING
Authors: IHARA H MIWA M DEYA K TORISU K
Citation: H. Ihara et al., MRI OF ANTERIOR CRUCIATE LIGAMENT HEALING, Journal of computer assisted tomography, 20(2), 1996, pp. 317-321
MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .4. (VOL 5, PG 1083, 1995)
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .4. (VOL 5, PG 1083, 1995), Bioorganic & medicinal chemistry letters, 5(18), 1995, pp. 2179-2179
MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .1.
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .1., Bioorganic & medicinal chemistry letters, 5(10), 1995, pp. 1065-1070
MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .2.
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K TAKADA H TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .2., Bioorganic & medicinal chemistry letters, 5(10), 1995, pp. 1071-1076
MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .3.
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .3., Bioorganic & medicinal chemistry letters, 5(10), 1995, pp. 1077-1082
MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .4.
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., MOLECULAR DESIGN OF NOVEL PGI(2) AGONISTS WITHOUT PG SKELETON .4., Bioorganic & medicinal chemistry letters, 5(10), 1995, pp. 1083-1086
PHARMACOLOGICAL EVALUATION OF COMBINED PGI(2) AGONISTS THROMBOXANE SYNTHASE INHIBITORS .1.
Authors: HAMANAKA N TAKAHASHI K NAGAO Y TORISU K SHIGEOKA S HAMADA S KATO H TOKUMOTO H KONDO K
Citation: N. Hamanaka et al., PHARMACOLOGICAL EVALUATION OF COMBINED PGI(2) AGONISTS THROMBOXANE SYNTHASE INHIBITORS .1., Bioorganic & medicinal chemistry letters, 5(10), 1995, pp. 1087-1090
SYNTHESIS AND REACTIONS OF MONOSILYLATED 1,3,5-HEXATRIYNE AND 1,3,5,7-OCTATETRAYNE - TOTAL SYNTHESIS OF CARYOYNENCINS
Authors: YAMAGUCHI M PARK HJ HIRAMA M TORISU K NAKAMURA S MINAMI T NISHIHARA H HIRAOKA T
Citation: M. Yamaguchi et al., SYNTHESIS AND REACTIONS OF MONOSILYLATED 1,3,5-HEXATRIYNE AND 1,3,5,7-OCTATETRAYNE - TOTAL SYNTHESIS OF CARYOYNENCINS, Bulletin of the Chemical Society of Japan, 67(6), 1994, pp. 1717-1725
Risultati: 1-9 |